oceanbiomedical.com - Nilai perusahaan marang pendapatan OCEA

Ocean Biomedical, Inc. (OCEA) relies on a contract model, outsourcing clinical trials and protein synthesis to external contractors. The current EV/Sales ratio reflects the business value relative to revenue excluding debt, where the mark captures this metric. The absence of in-house facilities provides the team with flexibility, while the focus on combating malaria opens access to a massive global market.
Rincian metrik keuangan lan pasar Ocean Bio (OCEA)

This indicator determines the enterprise value of the entire business, including net debt, relative to sales volume, filtering out emotional noise during sharp market fluctuations. By analyzing the EV-to-revenue multiple, an investor assesses whether the asset is overvalued or possesses growth potential, which for Ocean Biomedical, Inc. (OCEA) depends directly on the pace of patent commercialization and the success of clinical trials in onco-immunology.